{"date":"2026-03-20","count":36,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6676-2026-03-20-1806-1wpp3mb","company_id":"6676","company":"祥翊","market":"興櫃","industry":"生技醫療","date":"2026-03-20","time":"18:06:24","subject":"公告本公司董事會決議擬辦理私募普通股案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：祥翊（6676），2026-03-20 18:06，「公告本公司董事會決議擬辦理私募普通股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6676-2026-03-20-1804-11b1948","company_id":"6676","company":"祥翊","market":"興櫃","industry":"生技醫療","date":"2026-03-20","time":"18:04:13","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：祥翊（6676），2026-03-20 18:04，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6676-2026-03-20-1758-2iz4hx","company_id":"6676","company":"祥翊","market":"興櫃","industry":"生技醫療","date":"2026-03-20","time":"17:58:50","subject":"公告本公司董事會決議不發放股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：祥翊（6676），2026-03-20 17:58，「公告本公司董事會決議不發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6676-2026-03-20-1748-12of6u4","company_id":"6676","company":"祥翊","market":"興櫃","industry":"生技醫療","date":"2026-03-20","time":"17:48:06","subject":"公告本公司114年度累積虧損達實收資本額二分之一","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：祥翊（6676），2026-03-20 17:48，「公告本公司114年度累積虧損達實收資本額二分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7878-2026-03-20-1745-1qut4ld","company_id":"7878","company":"藥祇","market":"興櫃","industry":"生技醫療","date":"2026-03-20","time":"17:45:05","subject":"本公司董事會決議召開115年股東常會(更正2/26公告，新增報告事項及承認事項)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：藥祇（7878），2026-03-20 17:45，「本公司董事會決議召開115年股東常會(更正2/26公告，新增報告事項及承認事項)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6676-2026-03-20-1740-1xl66gd","company_id":"6676","company":"祥翊","market":"興櫃","industry":"生技醫療","date":"2026-03-20","time":"17:40:59","subject":"公告本公司董事會通過114年度個別財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：祥翊（6676），2026-03-20 17:40，「公告本公司董事會通過114年度個別財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6610-2026-03-20-1732-1howjn","company_id":"6610","company":"安成生技","market":"興櫃","industry":"生技醫療","date":"2026-03-20","time":"17:32:11","subject":"公告本公司董事會決議召開115年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安成生技（6610），2026-03-20 17:32，「公告本公司董事會決議召開115年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6782-2026-03-20-1729-y6v7a2","company_id":"6782","company":"視陽","market":"上市","industry":"生技醫療","date":"2026-03-20","time":"17:29:38","subject":"公告本公司取得不動產","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：視陽（6782），2026-03-20 17:29，「公告本公司取得不動產」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6704-2026-03-20-1711-d4432r","company_id":"6704","company":"國璽幹細胞","market":"興櫃","industry":"生技醫療","date":"2026-03-20","time":"17:11:11","subject":"公告本公司董事會決議現金增資發行新股。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：國璽幹細胞（6704），2026-03-20 17:11，「公告本公司董事會決議現金增資發行新股。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6704-2026-03-20-1710-11b1948","company_id":"6704","company":"國璽幹細胞","market":"興櫃","industry":"生技醫療","date":"2026-03-20","time":"17:10:07","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：國璽幹細胞（6704），2026-03-20 17:10，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6704-2026-03-20-1708-bwopfv","company_id":"6704","company":"國璽幹細胞","market":"興櫃","industry":"生技醫療","date":"2026-03-20","time":"17:08:55","subject":"公告本公司董事會決議不分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：國璽幹細胞（6704），2026-03-20 17:08，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6704-2026-03-20-1708-1utegip","company_id":"6704","company":"國璽幹細胞","market":"興櫃","industry":"生技醫療","date":"2026-03-20","time":"17:08:15","subject":"公告本公司董事會通過114年度財務報告。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：國璽幹細胞（6704），2026-03-20 17:08，「公告本公司董事會通過114年度財務報告。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7878-2026-03-20-1707-3kb7gv","company_id":"7878","company":"藥祇","market":"興櫃","industry":"生技醫療","date":"2026-03-20","time":"17:07:29","subject":"本公司董事會決議不發放股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：藥祇（7878），2026-03-20 17:07，「本公司董事會決議不發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6610-2026-03-20-1702-1erfaaw","company_id":"6610","company":"安成生技","market":"興櫃","industry":"生技醫療","date":"2026-03-20","time":"17:02:25","subject":"本公司董事會決議辦理私募普通股增資案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安成生技（6610），2026-03-20 17:02，「本公司董事會決議辦理私募普通股增資案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7878-2026-03-20-1702-otyru5","company_id":"7878","company":"藥祇","market":"興櫃","industry":"生技醫療","date":"2026-03-20","time":"17:02:22","subject":"本公司董事會決議通過114年度財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：藥祇（7878），2026-03-20 17:02，「本公司董事會決議通過114年度財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7832-2026-03-20-1651-11b1948","company_id":"7832","company":"智新生技*","market":"興櫃","industry":"生技醫療","date":"2026-03-20","time":"16:51:20","subject":"公告本公司董事會決議召開115年股東常會相關事宜","clause":"第32款","fact_date":"2026-03-20","cite_as":"公開資訊觀測站重大訊息：智新生技*（7832），2026-03-20 16:51，「公告本公司董事會決議召開115年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6666-2026-03-20-1637-k1h1bm","company_id":"6666","company":"羅麗芬-KY","market":"上市","industry":"生技醫療","date":"2026-03-20","time":"16:37:18","subject":"代重要子公司嘉文麗(福建)化妝品有限公司監事解任(補充公告)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：羅麗芬-KY（6666），2026-03-20 16:37，「代重要子公司嘉文麗(福建)化妝品有限公司監事解任(補充公告)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6857-2026-03-20-1633-54swv6","company_id":"6857","company":"宏碁智醫","market":"興櫃","industry":"生技醫療","date":"2026-03-20","time":"16:33:40","subject":"公告本公司法人董事改派代表人","clause":"第6款","fact_date":"2026-03-20","cite_as":"公開資訊觀測站重大訊息：宏碁智醫（6857），2026-03-20 16:33，「公告本公司法人董事改派代表人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7832-2026-03-20-1621-bwopfv","company_id":"7832","company":"智新生技*","market":"興櫃","industry":"生技醫療","date":"2026-03-20","time":"16:21:07","subject":"公告本公司董事會決議不分派股利","clause":"第31款","fact_date":"2026-03-20","cite_as":"公開資訊觀測站重大訊息：智新生技*（7832），2026-03-20 16:21，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7832-2026-03-20-1618-5j9yh6","company_id":"7832","company":"智新生技*","market":"興櫃","industry":"生技醫療","date":"2026-03-20","time":"16:18:09","subject":"公告本公司董事會通過114年度合併財務報告","clause":"第43款","fact_date":"2026-03-20","cite_as":"公開資訊觀測站重大訊息：智新生技*（7832），2026-03-20 16:18，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7832-2026-03-20-1615-drgvb6","company_id":"7832","company":"智新生技*","market":"興櫃","industry":"生技醫療","date":"2026-03-20","time":"16:15:26","subject":"公告本公司累積虧損達實收資本額二分之一","clause":"第44款","fact_date":"2026-03-20","cite_as":"公開資訊觀測站重大訊息：智新生技*（7832），2026-03-20 16:15，「公告本公司累積虧損達實收資本額二分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6926-2026-03-20-1539-10yb8rh","company_id":"6926","company":"聖安生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-20","time":"15:39:00","subject":"本公司受邀參加元富證券舉辦之法人說明會","clause":"第30款","fact_date":"2026-03-23","cite_as":"公開資訊觀測站重大訊息：聖安生醫（6926），2026-03-20 15:39，「本公司受邀參加元富證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6634-2026-03-20-1536-1qllfxk","company_id":"6634","company":"欣耀","market":"興櫃","industry":"生技醫療","date":"2026-03-20","time":"15:36:46","subject":"公告本公司高肝腎安全性乙醯胺酚止痛新藥SNP-810(安泰拿疼)取得印尼專利","clause":"第44款","fact_date":"2026-03-20","cite_as":"公開資訊觀測站重大訊息：欣耀（6634），2026-03-20 15:36，「公告本公司高肝腎安全性乙醯胺酚止痛新藥SNP-810(安泰拿疼)取得印尼專利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6827-2026-03-20-1526-1hfjzzd","company_id":"6827","company":"巨生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-20","time":"15:26:33","subject":"公告本公司董事會決議召開115年股東會常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：巨生醫（6827），2026-03-20 15:26，「公告本公司董事會決議召開115年股東會常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6827-2026-03-20-1510-6r49ey","company_id":"6827","company":"巨生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-20","time":"15:10:07","subject":"公告本公司董事會決議虧損撥補案暨不發放股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：巨生醫（6827），2026-03-20 15:10，「公告本公司董事會決議虧損撥補案暨不發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6827-2026-03-20-1502-xo2pc7","company_id":"6827","company":"巨生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-20","time":"15:02:38","subject":"公告本公司董事會決議辦理限制員工權利新股收回註銷減資事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：巨生醫（6827），2026-03-20 15:02，「公告本公司董事會決議辦理限制員工權利新股收回註銷減資事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6827-2026-03-20-1502-1xl66gd","company_id":"6827","company":"巨生醫","market":"興櫃","industry":"生技醫療","date":"2026-03-20","time":"15:02:01","subject":"公告本公司董事會通過114年度個別財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：巨生醫（6827），2026-03-20 15:02，「公告本公司董事會通過114年度個別財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4153-2026-03-20-1444-dxzrq3","company_id":"4153","company":"鈺緯","market":"上櫃","industry":"生技醫療","date":"2026-03-20","time":"14:44:42","subject":"更正本公司114年第4季合併財務報告iXBRL申報資訊之關係人交易","clause":"第53款","fact_date":"2026-03-20","cite_as":"公開資訊觀測站重大訊息：鈺緯（4153），2026-03-20 14:44，「更正本公司114年第4季合併財務報告iXBRL申報資訊之關係人交易」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6574-2026-03-20-1443-aqkmv1","company_id":"6574","company":"霈方","market":"上櫃","industry":"生技醫療","date":"2026-03-20","time":"14:43:08","subject":"本公司有價證券近期多次達公佈注意交易資訊標準，故公告相關訊息，以利投資人區別暸解。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：霈方（6574），2026-03-20 14:43，「本公司有價證券近期多次達公佈注意交易資訊標準，故公告相關訊息，以利投資人區別暸解。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1799-2026-03-20-1423-1cza5x2","company_id":"1799","company":"易威","market":"上櫃","industry":"生技醫療","date":"2026-03-20","time":"14:23:34","subject":"本公司有價證券近期多次達公布注意交易資訊標準，故公告相關訊息，以利投資人區別暸解。","clause":"第53款","fact_date":"2026-03-20","cite_as":"公開資訊觀測站重大訊息：易威（1799），2026-03-20 14:23，「本公司有價證券近期多次達公布注意交易資訊標準，故公告相關訊息，以利投資人區別暸解。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6931-2026-03-20-1402-t9pa6l","company_id":"6931","company":"青松健康","market":"上市","industry":"生技醫療","date":"2026-03-20","time":"14:02:35","subject":"代子公司青松沙鹿股份有限公司公告向關係人取得使用權資產","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：青松健康（6931），2026-03-20 14:02，「代子公司青松沙鹿股份有限公司公告向關係人取得使用權資產」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6931-2026-03-20-1402-w4ji8u","company_id":"6931","company":"青松健康","market":"上市","industry":"生技醫療","date":"2026-03-20","time":"14:02:12","subject":"代子公司青松大武股份有限公司公告向關係人取得使用權資產","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：青松健康（6931），2026-03-20 14:02，「代子公司青松大武股份有限公司公告向關係人取得使用權資產」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6666-2026-03-20-1350-u0fe9e","company_id":"6666","company":"羅麗芬-KY","market":"上市","industry":"生技醫療","date":"2026-03-20","time":"13:50:35","subject":"代重要子公司嘉文麗(福建)化妝品有限公司監事解任","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：羅麗芬-KY（6666），2026-03-20 13:50，「代重要子公司嘉文麗(福建)化妝品有限公司監事解任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6491-2026-03-20-1115-14ms2k","company_id":"6491","company":"晶碩","market":"上市","industry":"生技醫療","date":"2026-03-20","time":"11:15:14","subject":"澄清115年3月20日新聞媒體報導","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晶碩（6491），2026-03-20 11:15，「澄清115年3月20日新聞媒體報導」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6467-2026-03-20-1108-ajizij","company_id":"6467","company":"泰合","market":"興櫃","industry":"生技醫療","date":"2026-03-20","time":"11:08:59","subject":"公告本公司取得會計師內部控制制度專案審查報告(審查期間114/01/01~114/12/31)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰合（6467），2026-03-20 11:08，「公告本公司取得會計師內部控制制度專案審查報告(審查期間114/01/01~114/12/31)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7790-2026-03-20-0835-dd4el6","company_id":"7790","company":"思必瑞特","market":"興櫃","industry":"生技醫療","date":"2026-03-20","time":"08:35:58","subject":"(更正盈餘及資本公積轉增資配股)本公司董事會決議股利分派","clause":"第31款","fact_date":"2026-03-19","cite_as":"公開資訊觀測站重大訊息：思必瑞特（7790），2026-03-20 08:35，「(更正盈餘及資本公積轉增資配股)本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}